Abstract
Deficiency of alpha-1 antitrypsin (AAT) is caused by mutations in the SERPINA1 gene that results in low concentrations of AAT in circulation. The low AAT concentration can result in uninhibited neutrophil elastase activity in the lung, leading to pulmonary tissue damage and lung disease. Clinical evaluation for possible AAT deficiency includes two critical components: measuring AAT concentration in serum and identification of AAT deficiency alleles. In this chapter the methods by which AAT concentration can be measured in the clinical laboratory are described. The two most common methodologies for AAT quantification employ immunometric techniques, specifically nephelometry and turbidimetry, which are both based on light scatter technology. The AAT in the patient sample is combined with an anti-AAT polyclonal antibody solution leading to polymer formation and a proportional amount of subsequent light scatter. Descriptions of each method are presented, and specifics of quality control and assay parameters are discussed. A special discussion focuses on interpretation of results in the context of the different AAT genetic phenotypes and in the context of patients with active inflammatory conditions. Emerging techniques for AAT quantitation by mass spectrometry are also described given that both AAT quantitation and allele identification can be performed on the same assay.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DeMeo DL, Silverman EK (2004) Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59:259–264
Stoller JK, Aboussouan LS (2005) Alpha1-antitrypsin deficiency. Lancet 365:2225–2236
Salahuddin P (2010) Genetic variants of alpha1-antitrypsin. Curr Protein Pept Sci 11:101–117
Dykes DD, Miller SA, Polesky HF (1984) Distribution of alpha 1-antitrypsin variants in a us white population. Hum Hered 34:308–310
Aboussouan LS, Stoller JK (2009) Detection of alpha-1 antitrypsin deficiency: a review. Respir Med 103:335–341
Sandhaus RA, Turino G, Stocks J, Strange C, Trapnell BC, Silverman EK et al (2008) Alpha1-antitrypsin augmentation therapy for pi*mz heterozygotes: a cautionary note. Chest 134:831–834
Viedma JA, de la Iglesia A, Parera M, Lopez MT (1986) A new automated turbidimetric immunoassay for quantifying alpha 1-antitrypsin in serum. Clin Chem 32:1020–1022
Chen Y, Snyder MR, Zhu Y, Tostrud LJ, Benson LM, Katzmann JA et al (2011) Simultaneous phenotyping and quantification of alpha-1-antitrypsin by liquid chromatography-tandem mass spectrometry. Clin Chem 57(8):1161
Donato LJ, Karras RM, Katzmann JA, Murray DL, Snyder MR (2015) Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the s and z deficiency alleles. Respir Res 16:96
Donato LJ, Jenkins SM, Smith C, Katzmann JA, Snyder MR (2012) Reference and interpretive ranges for alpha(1)-antitrypsin quantitation by phenotype in adult and pediatric populations. Am J Clin Pathol 138:398–405
Bornhorst JA, Greene DN, Ashwood ER, Grenache DG (2013) Alpha1-antitrypsin phenotypes and associated serum protein concentrations in a large clinical population. Chest 143:1000–1008
Snyder MR, Katzmann JA, Butz ML, Wiley C, Yang P, Dawson DB et al (2006) Diagnosis of alpha-1-antitrypsin deficiency: an algorithm of quantification, genotyping, and phenotyping. Clin Chem 52:2236–2242
Bornhorst JA, Procter M, Meadows C, Ashwood ER, Mao R (2007) Evaluation of an integrative diagnostic algorithm for the identification of people at risk for alpha1-antitrypsin deficiency. Am J Clin Pathol 128:482–490
Crystal RG (1989) The alpha 1-antitrypsin gene and its deficiency states. Trends Genet 5:411–417
Stoller JK, Aboussouan LS (2012) A review of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 185:246–259
Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG et al (1996) Clinical features of individuals with pi*sz phenotype of alpha 1-antitrypsin deficiency. Alpha 1-antitrypsin deficiency registry study group. Am J Respir Crit Care Med 154:1718–1725
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Donato, L.J., Snyder, M.R., Greene, D.N. (2017). Measuring and Interpreting Serum AAT Concentration. In: Borel, F., Mueller, C. (eds) Alpha-1 Antitrypsin Deficiency . Methods in Molecular Biology, vol 1639. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7163-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7163-3_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7161-9
Online ISBN: 978-1-4939-7163-3
eBook Packages: Springer Protocols